Lower Respiratory Tract Infections Flashcards

1
Q

Lower respiratory Tract infections:

Acute (5)/Chronic (3) LRTI.

A

Acute LRTI:

  • Pneumonia
  • Bronchitis
  • Bronchiolitis
  • Legionnaires disease
  • Whooping cough

Chronic LRTI:

  • Tuberculosis
  • Aspergillosis
  • Cystic fibrosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q
Pneumonia: The basics
Definition?
Acquired?
How many people die PA?
presentation AT, T?
importance of identification?
A
  • An acute LRTI associated with recent developed radiological signs, infection of the lungs due to bacteria, virus or fungi.
  • May be acquired in the community (CAP) or hospital (HAP); associated risk factors.
  • Approximately 30,000 die PA in UK.
  • May present Atypically or Typically
  • May be caused by several organisms therefore accurate identification is essential to ensure appropriate treatment.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Classification of pneumonia:

A
  • Community acquired pneumonia (CAP)
  • Hospital acquired pneumonia (HAP)
  • Aspiration pneumonia
  • Recurrent pneumonia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Community Acquired pneumonia:
- Approx. percentage of cases per year?

  • when is it seen?
  • The stats: How many diagnosed at GP?
  • how many admitted to hospital?
  • how many die?
  • how does age affect?
A
  • Every year 0.5% to 1% of uk adults will have CAP (~320,000 - 640,000 people)
  • Mainly seasonal.
  • CAP is diagnosed in 5 -12% of patients presenting to their GP.
  • 22- 42% admitted to hospital.
  • 5 - 14% die in hospital
  • 50& of death occur in patients over 84 years or more.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Typical pneumonia: signs and symptoms:

A

Predominately respiratory: most commonly in elderly, may occur spontaneously in young adults.

Signs:

  • cough
  • cyanosis
  • Tachypnoea
  • Tachycardia

Symptoms:

  • Fever
  • Muscle aches
  • shakes/rigor
  • dsypnoea
  • sputum production (rust coloured)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Micro-organisms most commonly associated with Typical pneumonia CAP:

  • Common (1 + characteristic)
  • Uncommon (3)
A

Most common bacteria:
- Streptococcus pneumoniae (diplococcus gram +ve)

Less common:

  • Haemophilus influenzae
  • Staphylococcus aureus (CF)
  • Pseudomonas aeruginosa (CF)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Atypical pneumonia: signs and symptoms:

A

Predominately not respiratory. -common in very young and very old.
- S.pneumoniae not recovered from culture.

Signs:

  • Rash
  • Cyanosis
  • Tachypnoea
  • Tachycardia
  • Dry cough

Symptoms:

  • Headache
  • Confusion
  • Diarrhoea
  • Incontinence
  • No sputum
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Micro-organisms associated with atypical CAP:
- Most common (1)

  • Less common (3)
  • Don’t forget the viruses
A

Most common:
- Mycoplasma pneumoniae

Less common:

  • Legionella pneumophilia (legionnaires disease)
  • Chlamydophila psittaci (Psittacosis) (birds)
  • Chlamydophila pneumonia

Viruses:

  • Influenza A/B
  • Rhinovirus
  • Covid-19
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Radiological differences between atypical and typical pneumonia:

  • Typical
  • Atypical
A
  • Typical: Widespread consolidation

- Atypical: Patchy consolidation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Organisms that cause CAP and associated risk factors:

A

Risk Factor:
- Elderly/young, S.pneumoniae, M. pneumoniae, presents typical and atypical.

Smokers/travelers abroad, L.pnemoniae, present atypically.

Alcoholic/vagrants: S.pneumonia

Contact with animals/bird: Cl. psittaci, present atypical.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Hospital Acquired pneumonia: Stats:

A
  • 3rd most common hospital acquired infection (Nosocomial) (23% HAI)
  • Patient may present with typical/atypical symptoms as described previously.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Risk factors for HAP include: (3)

A
  • Ventilation support: Klebsiella pneumoniae, Pseudomonas aeruginosa. (hospital flora): VAP ~48hrs or more following incubation.
  • Immunosupression: organ transplants - aspergillus fumigatus
  • immobility and vomiting: Aspiration pneumonia - oral bacteria e.g. viridians streptococci and anaerobic bacteria.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Treatment of pneumonia:

  • Uncomplicated CAP?
  • Severe CAP of unknown aetiology?
  • Atypical Pneumonia (CAP/HAP)
  • HAP?
A
  • Uncomplicated CAP: Amoxicillin or erythromycin, moxifloxacin is used now the other two show resistance.
  • Sever CAP of unknown aetiology: Cefuroxime and erythromycin
  • Atypical pneumonia: Erythromycin
  • HAP: Cefotaxime +/- Gentamycin.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Streptococcus pneumonia mechanism of pathogenicity:

  • Most common where? CAP/HAP?
  • Capsule?
  • avoiding host defense?
  • how many types of capsular.
  • ~how many serotypes cause serious disease?
  • Vaccine?
A
  • S.pneumoniae: most common cause of CAP
  • Capsule (A major virulence factor) (Polysaccharide)
  • Antiphagocytic (evasion)
  • 92 different capsular types; serotypes differ virulence.

90% pneumonia are caused by about 23 serotypes (used to develop vaccine PPSV23; Pneumococcal pneumoniae vaccine 23).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Mechanism of pathogenicity:

  • Adhesion protein?
  • Protection proteins? avoiding host defense. (2)
  • Toxin released proteins (2)?
A
  • CbpA: a major pneumoccocal adhesion protein (adhesin). The adhesion interacts with carbohydrates on pulmonary epithelial surface.
  • PspA (protective antigen): inhibits complement-mediated opsonizations.
  • IgA1 protease: Cleaves IgA1 the principle immunoglobulin isotype for the respiratory tract.
  • Autolysin: (LytA, LytB, LytC): breaks peptide cross linking in cell wall peptidoglycan releasing cell wall components; massive inflammation and pneumolysin release.
  • Pneumolysin: Toxin released during autolysis: inhibits neutrophil chemotaxis, phagocytosis, lymphocyte proliferation and immunoglobulin synthesis. `
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q
Laboratory investigation:
Specimen? 
Non-culture techniques?
Safety? 
Identification?
A

Sample: early morning Sputum.

  • Non-culture: Microscopy, gram-stain, lateral flow.
  • Culture: - Sputum & Sputolysin (N-acetylcysteine)
    - Blood Agar: 37, 5%CO2, 24hrs + optochin disc
    - Chocolate Agar: 37, 5% CO2 24hrs).

Safety consideration:

  • S.pneumonia: cat 2
  • Sputum sample: cat 3; class one safety cabinet.

Identification:
- Basic: Colonial appearance: S.pneumonia grows as an alpha hemolytic.
- Gram positive diplococci.
Full: optochin sensitivity differentiates S. pneumonia from normal oral streps.

17
Q

S. pneumonia:
Antigen detection urine?

Sensitivity testing and resistance?

Vaccination?

A

Antigen detection utilizes urine sample.

  • Non-culture technique: Immunochromographic assay/lateral flow assay.
  • Sample = urine
  • Rabbit anti-strep pneumoniae bound to nitrocellulose membrane.
  • urine is added.
  • 86% sensitivity, 94% specificity.
  • Diagnosis if positive: however negative does not rule out infection.

Sensitivity testing/treatment and prevention:
- S. pneumoniae is susceptible to penicillin and almost all antibiotics.

  • Penicillin resistance S. pneumoniae (DRSP) now widespread. eg. tetracycline, macrolides, trimethoprim-sulfamethoxazole. - 25% multi-drug resistance.
  • Fluoroquinolones remain active: moxifloxacin

Vaccines:
- 23 valent pneumococcal polysaccharide vaccine (PPSV23).

  • childhood vaccines: Pneumococcal conjugated vaccine (PCV13).